Drug Sponsors

BioCryst Pharmaceuticals to merge with Presidio Pharmaceuticals

Friday, October 19, 2012 11:34 AM

BioCryst Pharmaceuticals, a Durham, N.C.-based and developer of novel small molecule drugs that block key enzymes involved in infectious and inflammatory diseases, and Presidio Pharmaceuticals, a San Francisco-based clinical stage specialty pharmaceutical company, have signed a definitive merger agreement for Presidio to be acquired by BioCryst in an all-stock transaction.

More... »

Merck Serono, Auxogyn collaborate on Eeva Test

Friday, October 19, 2012 11:01 AM

Merck Serono, the biopharmaceutical division of Merck, and Auxogyn, a company focused on translating scientific discoveries in early embryo development into clinical tools, have entered into a strategic agreement focused on Auxogyn's proprietary Early Embryo Viability Assessment (Eeva) Test.

More... »

Clinical research sites honor Eli Lilly, Medpace with Eagle Awards

Monday, October 15, 2012 11:57 AM

The 2012 Eagle Awards, presented to the top sponsor and top CRO as voted by clinical research sites, honored Eli Lilly and Medpace on Saturday, Oct. 13, at the annual Site Solutions Summit.

More... »

Oramed, Medpace to collaborate on phase II trial

Monday, October 15, 2012 11:54 AM

Oramed, a subsidiary of Jerusalem-based Oramed Pharmaceuticals, a developer of oral drug delivery systems, has retained Medpace as CRO for Oramed's upcoming phase II clinical trial on its oral insulin capsule, ORMD-0801.

More... »

Pharmaron forms strategic partnership with AstraZeneca

Monday, October 15, 2012 11:47 AM

Pharmaron, an R&D service provider for the pharmaceutical and biotech industries, is partnering with AstraZeneca to support its global innovative medicines units.

More... »

Fate Therapeutics names Christian Weyer president, CEO

Monday, October 15, 2012 11:44 AM

San Diego, Calif.-based Fate Therapeutics has appointed Christian Weyer, M.D., M.A.S., president and CEO, and elected him to the board of directors, effective immediately.

More... »

Recipharm, Astimex form development and manufacturing collaboration

Friday, October 12, 2012 11:58 AM

Recipharm, a Swedish contract development and manufacturing organization, and Astimex Pharma, a Swedish pharmaceutical company, have formed a collaboration agreement for the development and manufacture of a pharmaceutical product.

More... »

GSK announces initiatives to advance openness and collaboration for global health challenges

Friday, October 12, 2012 11:04 AM

Global healthcare company GlaxoSmithKline has announced new measures to further advance its commitment towards greater openness, transparency and collaboration, designed to help develop new solutions for the world’s most serious health challenges.

More... »

ImaginAb, Lundbeck to collaborate in neurodegeneration

Wednesday, October 10, 2012 12:49 PM

ImaginAb, an Inglewood, Calif.-based clinical-stage company developing in vivomolecular imaging agents, has entered into a collaboration and commercialization agreement with Lundbeck, an international pharmaceutical company, on a novel central nervous system (CNS) target in order to explore the use of re-engineered antibodies to accelerate the blood-brain barrier (BBB) transport of biologics.

More... »

QRxPharma inks strategic collaboration with Paladin Labs

Wednesday, October 10, 2012 11:31 AM

QRxPharma, a commercial-stage specialty pharmaceutical company based in Bedminster, N.J., signed a licensing agreement with Paladin Labs, specialty pharmaceutical company based in Montreal, for the Canadian commercialization rights to Moxduo, a patented, immediate-release formulation of morphine and oxycodone. 

More... »